Advanced Strategies for Remimazolam Application
THE JOURNAL OF JAPAN SOCIETY FOR CLINICAL ANESTHESIA · 15.11.2025 · 45 (6) · 601-607
DOI: 10.2199/jjsca.45.601 ↗Kurz gefasst
Fachartikel in der Zeitschrift THE JOURNAL OF JAPAN SOCIETY FOR CLINICAL ANESTHESIA, erschienen am 15.11.2025. Verfasst von Kotoe KAMATA.
Abstract (Originalsprache)
Remimazolam besylate, an ultra-short-acting benzodiazepine, has become familiar in our clinical practice. Its pharmacological properties of short duration and having a specific antagonist are considerable advantages, especially in cases where delayed emergence is a concern. However, its short-acting property also poses a risk:inappropriate dosing adjustments may lead to intraoperative awareness. Therefore, safe and effective anesthesia with remimazolam requires the ability to accurately assess its sedative effect. This article discusses advanced strategies for anesthetic management utilizing the unique pharmacokinetic and pharmacodynamic characteristics of remimazolam, based on the author’s personal experience and a review of the current literature.
Zitieren
APA
KAMATA, K. (2025). Advanced Strategies for Remimazolam Application. THE JOURNAL OF JAPAN SOCIETY FOR CLINICAL ANESTHESIA, 45(6), 601-607. https://doi.org/10.2199/jjsca.45.601
Vancouver
KAMATA K. Advanced Strategies for Remimazolam Application. THE JOURNAL OF JAPAN SOCIETY FOR CLINICAL ANESTHESIA. 2025;45(6):601-607. doi:10.2199/jjsca.45.601
BibTeX
@article{KAMATA2025,
author = {KAMATA, Kotoe},
title = {Advanced Strategies for Remimazolam Application},
journal = {THE JOURNAL OF JAPAN SOCIETY FOR CLINICAL ANESTHESIA},
year = {2025},
volume = {45},
number = {6},
pages = {601--607},
doi = {10.2199/jjsca.45.601}
}
EUVIMED